Aptevo TherapeuticsAPVO
13F holders, Q3 2025 (September 30)12holders +6
6new positions
0sold out
1famous investor
$1.45avg. 13F price*
At the end of Q3 2025, 12 institutions reported holding Aptevo Therapeutics Inc. (APVO) in their 13F filings, up 6 from Q2 2025. 6 opened new positions and 0 sold out. The largest holders were Point72 Asset Management ($435K), DRW Securities, LLC ($191K) and Virtu Financial LLC ($56K). One famous investor held it Steve Cohen (0.0% of Point72 Asset Management's portfolio).
- Company
- Aptevo Therapeutics Inc.
- CUSIP
- 03835L504
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $704K |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 488,980 shares bought and 18 shares sold, net +488,962 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Point72 Asset Management | 0.00% | New | 299,944 | $435K |
| DRW Securities, LLC | 0.01% | New | 131,480 | $191K |
| Virtu Financial LLC | 0.00% | New | 38,282 | $56K |
| Focus Partners Wealth | 0.00% | New | 10,000 | $15K |
| Osaic Holdings, Inc. | 0.00% | Add +100.0% | 6,500 | $10K |
| UBS Group AG | 0.00% | New | 5,673 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +21.2% | 1,445 | $2K |
| SBI Securities Co., Ltd. | 0.00% | Reduce -3.1% | 570 | $827 |
| Citigroup Inc. | 0.00% | New | 74 | $107 |
| Bank of America Corp. | 0.00% | Add +800.0% | 27 | $39 |
| Danske Bank A/S | 0.00% | No change | 1 | $1 |
| BlackRock, Inc. | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is APVO's weight in each manager's 13F, not the share of Aptevo Therapeutics Inc. the manager owns.